SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-003222
Filing Date
2022-03-09
Accepted
2022-03-09 16:05:46
Documents
14
Period of Report
2022-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mirm-20220309.htm   iXBRL 8-K 54649
2 EX-99.1 mirm-ex99_1.htm EX-99.1 282022
3 GRAPHIC img233628718_0.jpg GRAPHIC 7945
  Complete submission text file 0000950170-22-003222.txt   488668

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mirm-20220309_pre.xml EX-101.PRE 10831
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mirm-20220309_lab.xml EX-101.LAB 14720
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mirm-20220309.xsd EX-101.SCH 2501
8 EXTRACTED XBRL INSTANCE DOCUMENT mirm-20220309_htm.xml XML 5112
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 22725421
SIC: 2834 Pharmaceutical Preparations